Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2026-01-06 @ 10:23 PM
Study NCT ID:
NCT02535650
Status:
UNKNOWN
Last Update Posted:
2022-03-08
First Post:
2015-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-06
Completion Date Type:
ESTIMATED
First Submit Date:
2015-08-25
First Submit QC Date:
None
Study First Post Date:
2015-08-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-06
Last Update Post Date:
2022-03-08
Last Update Post Date Type:
ACTUAL